McMaster Health Sciences @machealthsci · 15 Aug 2025
Heart failure drug spironolactone fails to lower cardiovascular risk in dialysis patients. Michael Walsh, principal investigator, @PHRIresearch scientist and @MacDeptMed associate professor, explains the “much-needed clarity” the study's findings provide. https://t.co/OGOzqUV5hn
1 092Views
6Likes
3Reposts
13Replies
0Quotes
0Bookmarks
Is that a lot?
0.48×vs 10K–100K median2 259 views is typical
8.49%Reachviews ÷ followers
2.02%Engagement rateof viewers reacted